UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of Klaviyo, Inc. (NYSE:KVYO - Free Report) by 76.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 105,178 shares of the company's stock after acquiring an additional 45,523 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in Klaviyo were worth $4,338,000 as of its most recent SEC filing.
A number of other large investors have also made changes to their positions in KVYO. Renaissance Capital LLC raised its stake in shares of Klaviyo by 56.4% during the 4th quarter. Renaissance Capital LLC now owns 122,646 shares of the company's stock worth $5,058,000 after buying an additional 44,245 shares during the last quarter. Wilmington Savings Fund Society FSB lifted its position in Klaviyo by 17,445.7% during the fourth quarter. Wilmington Savings Fund Society FSB now owns 16,142 shares of the company's stock worth $666,000 after buying an additional 16,050 shares during the period. WCM Investment Management LLC purchased a new position in shares of Klaviyo during the 4th quarter worth about $12,781,000. Legato Capital Management LLC raised its stake in Klaviyo by 21.7% during the fourth quarter. Legato Capital Management LLC now owns 40,032 shares of the company's stock worth $1,651,000 after purchasing an additional 7,142 shares during the period. Finally, New York State Common Retirement Fund boosted its holdings in Klaviyo by 41.0% in the fourth quarter. New York State Common Retirement Fund now owns 22,297 shares of the company's stock valued at $920,000 after acquiring an additional 6,488 shares during the last quarter. Hedge funds and other institutional investors own 45.43% of the company's stock.
Wall Street Analyst Weigh In
KVYO has been the subject of several research reports. Mizuho decreased their price objective on shares of Klaviyo from $52.00 to $40.00 and set an "outperform" rating for the company in a research note on Tuesday, April 15th. Benchmark boosted their price objective on Klaviyo from $43.00 to $44.00 and gave the company a "buy" rating in a report on Wednesday, May 7th. Morgan Stanley reduced their price target on shares of Klaviyo from $50.00 to $34.00 and set an "equal weight" rating on the stock in a research report on Wednesday, April 16th. Robert W. Baird reduced their price objective on Klaviyo from $54.00 to $37.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Finally, Wells Fargo & Company upped their target price on shares of Klaviyo from $26.00 to $32.00 and gave the stock an "equal weight" rating in a research report on Monday, May 5th. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Klaviyo has a consensus rating of "Moderate Buy" and an average target price of $42.79.
Check Out Our Latest Analysis on KVYO
Insiders Place Their Bets
In related news, major shareholder Jeff Fagnan bought 3,900 shares of Klaviyo stock in a transaction that occurred on Wednesday, April 9th. The stock was acquired at an average price of $25.77 per share, for a total transaction of $100,503.00. Following the completion of the purchase, the insider now owns 3,900 shares in the company, valued at approximately $100,503. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Carmel Galvin sold 11,156 shares of Klaviyo stock in a transaction that occurred on Friday, May 16th. The stock was sold at an average price of $35.01, for a total value of $390,571.56. Following the sale, the insider now directly owns 711,805 shares in the company, valued at $24,920,293.05. The trade was a 1.54% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 10,087,320 shares of company stock valued at $333,128,245 over the last three months. 49.92% of the stock is currently owned by insiders.
Klaviyo Stock Up 0.4%
Shares of KVYO traded up $0.14 during trading hours on Friday, reaching $34.09. The company's stock had a trading volume of 1,022,063 shares, compared to its average volume of 1,519,648. The firm has a market cap of $10.12 billion, a price-to-earnings ratio of -189.60 and a beta of 1.44. The company has a 50 day moving average of $30.83 and a two-hundred day moving average of $36.96. Klaviyo, Inc. has a 1-year low of $21.26 and a 1-year high of $49.55.
Klaviyo (NYSE:KVYO - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.02. The company had revenue of $279.83 million for the quarter, compared to analyst estimates of $267.79 million. Klaviyo had a positive return on equity of 0.89% and a negative net margin of 4.92%. The business's revenue was up 33.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.13 EPS. As a group, analysts forecast that Klaviyo, Inc. will post 0.04 EPS for the current fiscal year.
About Klaviyo
(
Free Report)
Klaviyo, Inc, a technology company, provides a software-as-a-service platform in the United States, other Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers Klaviyo, a cloud-native platform for data store, segmentation engine, campaigns and flows, and messaging infrastructure.
Read More

Before you consider Klaviyo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Klaviyo wasn't on the list.
While Klaviyo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.